GlycosBio Inc.
Activated Oil Systems—engineered lipid molecules designed for therapeutic delivery using advanced enzymatic processing
- Sector
- Biotech
- Headquarters
- Houston, TX
- Founded
- 2007
- Latest Form D
- $1.1M, Mar 2024
- Total capital
- $16.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $16.5M
- 8 Form D · last Mar 2024
- 31 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 14 pending · first 2023
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 8th filing$1.1M
- Private capital raisedForm D · SEC · 7th filing$425K
- Private capital raisedForm D · SEC · 6th filing$830K
- Private capital raisedForm D · SEC · 5th filing$375K
- Private capital raisedForm D · SEC · 4th filing$3M
- Private capital raisedForm D · SEC · 3rd filing$4.2M
- Private capital raisedForm D · SEC · 2nd filing$4.2M
- Private capital raisedForm D · SEC · 1st filing$2.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Dan C. Jr. WatkinsDirectorNamed in SEC Form D filings
- Frank C. Jr. FosterDirectorNamed in SEC Form D filings
- John C. Jr. ReplogleDirectorNamed in SEC Form D filings
- Joseph C. Jr. WalowskiDirectorNamed in SEC Form D filings
- Richard C. Jr. CilentoExecutive Officer, DirectorNamed in SEC Form D filings
- Victoria C. Jr. NiklasDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 15- PendingPersonal Care Compositions With Enzyme-modified Oils (emos)USPTOApplication 19361239
- PendingMonoacylglycerol And Free Fatty Acid-based Compositions, Methods Of Manufacturing And Use Of The SameUSPTOApplication 18379470
- PendingDrug Delivery Via Monoacylglycerol And Free Fatty Acid-based CompositionsUSPTOApplication 18379449
Show all 15 patent records
- Personal Care Compositions With Enzyme-modified Oils (emos)Feb 26, 2026 · Application 19361239Pending
- Monoacylglycerol And Free Fatty Acid-based Compositions, Methods Of Manufacturing And Use Of The SameFeb 29, 2024 · Application 18379470Pending
- Drug Delivery Via Monoacylglycerol And Free Fatty Acid-based CompositionsFeb 15, 2024 · Application 18379449Pending
- Method Of Making Monoacylglyceride Oils And Food Products Containing Monoacylglyceride OilsJul 20, 2023 · Application 18155441Pending
- Method Of Making Monoacylglyceride Oils And Food Products Containing Monoacylglyceride OilsFeb 21, 2023 · US 11,582,982Granted
- Latex-compatible Oil-based CompositionsApplication 63534035Pending
- Personal Care Compositions With Enzyme-modified Oils (emos)Application 63497630Pending
- Latex-compatible Oil-based CompositionsApplication PCTUS2024043335Pending
- Monoacylglycerol And Free Fatty Acid-based Compositions, Methods Of Manufacturing And Use Of The SameApplication PCTUS2022024711Pending
- Personal Care Compositions With Enzyme-modified Oils (emos)Application PCTUS2024025563Pending
- Monoacylglycerol And Free Fatty Acid-based Nanoemulsions And Methods Of Manufacturing The SameApplication 63292862Pending
- Monoacylglycerol And Free Fatty Acid-based Nanoemulsions And Methods Of Manufacturing The SameApplication 63197896Pending
- Drug Delivery Via Monoacylglycerol And Free Fatty Acid-based NanoemulsionsApplication 63197905Pending
- Method Of Making Monoacylglyceride Oils And Food Products Containing Monoacylglyceride OilsApplication PCTUS2020014182Pending
- Drug Delivery Via Monoacylglycerol And Free Fatty Acid-based CompositionsApplication PCTUS2022024709Pending
Related companies, and why
- Eilean TherapeuticsSimilar federal contract value in Biotech · null in contracts
- ELEUTHERIA PHARMACEUTICALS LLCSimilar federal contract value in Biotech · null in contracts
- STEMETIX, INC.Similar federal contract value in Biotech · null in contracts
- ARONORA INCSimilar federal contract value in Biotech · null in contracts
- MABVAX THERAPEUTICS HOLDINGS, INC.Similar federal contract value in Biotech · null in contracts
- BIOTIME, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .